Navigation Links
El Proyecto Recuperación transforma hemoderivados en medicina para la hemofilia en países en desarrollo
Date:9/26/2013

encia y las sólidas relaciones con todos aquellos que nos han impulsado hasta ahora ayudarán a miles de pacientes que merecen tratamiento".

Esta donación de Haemoctin supone un hito para la WFH. El proyecto permitirá a la WFH ampliar su Programa de Ayuda Humanitaria como parte de sus exhaustivas actividades para hacer realidad el tratamiento de todas las personas con trastornos hemorrágicos.

Acerca de la hemofilia y otros trastornos hemorrágicos
La hemofilia, la enfermedad de von Willebrand, las alteraciones heredadas de plaquetas y otras deficiencias de factor constituyen trastornos hemorrágicos de por vida que impiden la correcta coagulación de la sangre. Las personas que sufren un trastorno de coagulación no tienen determinado factor de coagulación o una proteína en sangre que controla las hemorragias en cantidades suficientes, o bien no funcionan adecuadamente. La gravedad de un trastorno hemorrágico suele depender del faltante o la inoperatividad del factor coagulante alterado. Las personas con hemofilia pueden padecer hemorragias no controladas derivadas de heridas de aparentemente poca importancia. El sangrado al interior de articulaciones y músculos es sumamente doloroso y puede causar discapacidad, mientras que el sangrado al interior de órganos importantes, como el cerebro, puede provocar la muerte.

Acerca de BIOTEST AG
BIOTEST se especializa en la hematología y la inmunología innovadoras gracias a un enfoque integral de un grupo de productos farmacéuticos y de bioterapia que operan en todo el mundo, y desarrolla, fabrica y vende productos medicinales para el tratamiento de trastornos de la sangre y del sistema inmunológico. El principal material de base para los productos farmacéuticos de BIOTEST es el plasma humano; este se procesa para fabricar productos medicinales empleados en el tratamiento de alteraciones que ponen en riesgo
'/>"/>

SOURCE World Federation of Hemophilia
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New Annual US$3 Million Fundamental Physics Prize Recognizes Transformative Advances in the Field
2. Transformation Dental Partners Launch Ground Breaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
3. Industry Thought Leader to Present Transformational Opportunities for Industry Adoption of Advanced Analytics at 2013 HIMSS Annual Conference & Exhibition
4. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... address unmet medical needs in the areas of inflammation, ... presenting preclinical data from three of its biodefense programs ... Technology Conference on May 12-14, 2015 to be held ... Plaza, St. Louis MO 63101. ...
(Date:5/4/2015)... 2015   Sentrian ™, the Remote Patient Intelligence™ ... the Scripps Translational Science Institute (STSI) to ... with chronic obstructive pulmonary disease (COPD), a chronic condition ... nation,s third leading cause of death. The patients are ... , a wholly owned subsidiary of Anthem.   ...
(Date:5/1/2015)... , May 1, 2015 Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its first quarter 2015 financial results ... before the open of market. At 8:30 am Eastern ... to discuss the financial results and provide a ...
(Date:5/1/2015)... May 1, 2015 According ... Market by Product (Equipment, Consumables), by Type (Monoclonal, Polyclonal), ... Labs, Research Institutes) - Analysis & Global Forecast ... the global Antibody Production Market for the forecast ... expected to reach $2.572 Billion by 2019 from ...
Breaking Biology Technology:Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 2CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 4CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 5Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4
... Professor Harry Dorn has developed a new area of fullerene ... semiconductors and quantum computing applications. , Dorn plays with ... are tinker toys. First, in 1999, he figured out how ... do it reliably, how to change the number of atoms ...
... (Nasdaq: PRXL ), a leading global biopharmaceutical ... the,first quarter of Fiscal Year 2009 (ending September ... conjunction with the successful completion of the,acquisition of ... Josef von Rickenbach, Chairman and Chief Executive Officer ...
... Annual Meeting, FREMONT, Calif., Sept. 8 Vermillion, ... today that a,team of scientists at Stanford University and ... the Annual General Meeting of the,PAD Coalition. Led by ... T.,Fung, Chief Scientific Officer at Vermillion, Inc., the research ...
Cached Biology Technology:Carbon molecule with a charge could be tomorrow's semiconductor 2PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 2PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 3PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 4PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 5Vermillion and Stanford Scientists Receive 'Best Research Award' From the PAD Coalition 2Vermillion and Stanford Scientists Receive 'Best Research Award' From the PAD Coalition 3
(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
(Date:4/2/2015)... Fingerprint Cards (FPC) has received ... the distributor World Peace Industrial Group (WPI), part of ... the major part of the shipments will take place ... smartphone manufacturers in China . The ... communicated revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... Nanoparticle films are no longer a delicate matter: Vanderbilt ... so they don,t disintegrate at the slightest touch. In ... to create nanoparticles ultrafine particles with diameters less than ... of different methods to mold them into thin films which ...
... that a new colon cancer screening technique created by ... it could potentially be as or more successful than ... technique uses optical technology, called low-coherence enhanced backscattering (LEBS) ... of the rectum. Light shines on the tissue, scatters, ...
... Sustainable Energy Technologies was chosen for multiple reasons: to ... change, to provide society with security of energy supply ... For this a European graduate school is thought to ... of thought, to foster the development of excellent young ...
Cached Biology News:Researchers create freestanding nanoparticle films without fillers 2Researchers create freestanding nanoparticle films without fillers 3Colon cancer screening technique shows continued promise in new study 2
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),...
Prepared from plasminogen by activation with immobilized human uPA...
Human FADD Affinity Purified Polyclonal Ab...
(3-[125I]iodotyrosyl26)Galanin (porcine), 925 kBq, 25 uCi. Category: IODINE LIGANDS....
Biology Products: